Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen is among the pharmaceutical firms impacted by President Trump's demand for 17 companies, including Novo Nordisk, to lower U.S. drug prices to "most favored nation" levels by September 29. Additionally, AbbVie is set to release its quarterly earnings report on July 31, 2025, which may provide insights relevant to investors in the pharmaceutical sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
